Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodolfo Montironi

Showing results (31-40 of 801) with videos related to

Pageof 81
Sort By:
The New England Journal of Medicine|July 6, 2018
Immune Checkpoint Blockade in Advanced Renal-Cell CarcinomaMatteo Santoni, Rodolfo Montironi, Nicola Battelli
Archives of Pathology & Laboratory Medicine|March 31, 2012
Implications of the International Society of Urological Pathology modified Gleason grading systemLars Egevad, Roberta Mazzucchelli, Rodolfo Montironi
European Urology|January 2, 2008
Editorial comment on: Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective studyRodolfo Montironi, Antonio Lopez-Beltran, Liang Cheng
European Urology|October 11, 2025
Histopathology-only Artificial Intelligence for Prostate Cancer: Towards Accessible Risk StratificationIrbaz Bin Riaz, Liang Cheng, Rodolfo Montironi
Acta Oncologica (Stockholm, Sweden)|May 25, 2011
Pathology in prostate research: optimizing tissue qualityDaniel M Berney, Rodolfo Montironi, Lars Egevad
European Urology|January 15, 2015
Words of wisdom. Re: Antibody-drug conjugates targeting prostate-specific membrane antigenRodolfo Montironi, Antonio Lopez-Beltran, Liang Cheng
European Urology|April 9, 2008
Editorial comment on: comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey Clinic Medical Center experience and an international meta-analysisRodolfo Montironi, Liang Cheng, Antonio Lòpez Beltran
European Urology|January 2, 2017
TERT Promoter Mutations Occur Frequently in Urothelial Papilloma and Papillary Urothelial Neoplasm of Low Malignant PotentialLiang Cheng, Rodolfo Montironi, Antonio Lopez-Beltran
Acta Oncologica (Stockholm, Sweden)|May 25, 2011
Pathology in prostate research: optimizing the pathological dataDaniel M Berney, Rodolfo Montironi, Lars Egevad
Current Drug Metabolism|November 9, 2017
Editorial: Emerging Biomarkers in Genitourinary TumorsRodolfo Montironi, Antonio Lopez-Beltran, Liang Cheng
Pageof 81

Showing results (31-40 of 801) with videos related to

Sort By:
Pageof 81
The New England Journal of Medicine|July 6, 2018
Immune Checkpoint Blockade in Advanced Renal-Cell CarcinomaMatteo Santoni, Rodolfo Montironi, Nicola Battelli
Archives of Pathology & Laboratory Medicine|March 31, 2012
Implications of the International Society of Urological Pathology modified Gleason grading systemLars Egevad, Roberta Mazzucchelli, Rodolfo Montironi
European Urology|January 2, 2008
Editorial comment on: Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective studyRodolfo Montironi, Antonio Lopez-Beltran, Liang Cheng
European Urology|October 11, 2025
Histopathology-only Artificial Intelligence for Prostate Cancer: Towards Accessible Risk StratificationIrbaz Bin Riaz, Liang Cheng, Rodolfo Montironi
Acta Oncologica (Stockholm, Sweden)|May 25, 2011
Pathology in prostate research: optimizing tissue qualityDaniel M Berney, Rodolfo Montironi, Lars Egevad
European Urology|January 15, 2015
Words of wisdom. Re: Antibody-drug conjugates targeting prostate-specific membrane antigenRodolfo Montironi, Antonio Lopez-Beltran, Liang Cheng
European Urology|April 9, 2008
Editorial comment on: comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey Clinic Medical Center experience and an international meta-analysisRodolfo Montironi, Liang Cheng, Antonio Lòpez Beltran
European Urology|January 2, 2017
TERT Promoter Mutations Occur Frequently in Urothelial Papilloma and Papillary Urothelial Neoplasm of Low Malignant PotentialLiang Cheng, Rodolfo Montironi, Antonio Lopez-Beltran
Acta Oncologica (Stockholm, Sweden)|May 25, 2011
Pathology in prostate research: optimizing the pathological dataDaniel M Berney, Rodolfo Montironi, Lars Egevad
Current Drug Metabolism|November 9, 2017
Editorial: Emerging Biomarkers in Genitourinary TumorsRodolfo Montironi, Antonio Lopez-Beltran, Liang Cheng
Pageof 81